Physician profile
Michael Lawrenz Ferreras Co
NPI 1295110625
$85,837.26
in general payments reported to CMS, 2019-2025
21 companies · $12K in 2025
The $12K reported for 2025 was more than what 83% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,799 · 2020: $4,356 · 2021: $17K · 2022: $28K · 2023: $14K · 2024: $7,007 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $21K · Food and Beverage: $11K · Grant: $1,427 · Education: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $20,569.53 |
| Food and Beverage | $10,760.86 |
| Grant | $1,427.44 |
| Education | $304.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $41,815.17 | 2021-2025 | Micra, Evera Mri Xt Dr Surescan, Selectsecure |
| Biotronik INC. | $20,257.90 | 2020-2025 | Acticor 7 Vr-T Dx, Biomonitor, Selectra |
| Abbott Laboratories | $9,887.85 | 2019-2025 | Ensite Precision, Ensite, Aveir |
| Boston Scientific Corporation | $8,198.26 | 2019-2025 | Farapulse, Rhythmia Mapping System, Watchman Access System |
| Medical Device Business Services, INC. | $2,436.36 | 2022 | |
| Medtronic Vascular, INC. | $1,000.00 | 2019 | |
| Baylis Medical Company INC | $510.42 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $331.09 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $259.73 | 2019-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $167.71 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $125.00 | 2020 | |
| Novartis Pharmaceuticals Corporation | $116.60 | 2019 | |
| Ge Healthcare | $111.37 | 2019 | |
| Sanofi-Aventis U.S. LLC | $108.80 | 2022 | |
| Baxter Healthcare | $104.01 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $102.02 | 2022 | |
| Philips North America LLC | $93.31 | 2022 | |
| Biosense Webster, INC. | $90.20 | 2022 | |
| Pfizer INC. | $58.30 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $41.06 | 2022-2023 | Camzyos |
| Cardiva Medical, INC. | $22.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lawrenz Co listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.